chr21-34886935-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
This summary comes from the ClinGen Evidence Repository: NM_001754.4(RUNX1):c.259G>T (p.Gly87Cys) is a missense variant which has a REVEL score ≥ 0.88 (0.918) (PP3). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PP3. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014559/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152202Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460822Hom.: 0 Cov.: 35 AF XY: 0.00000275 AC XY: 2AN XY: 726780
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74488
ClinVar
Submissions by phenotype
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:3
This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 87 of the RUNX1 protein (p.Gly87Cys). This variant is present in population databases (rs561166961, gnomAD 0.003%). This missense change has been observed in individual(s) with iMCD-TAFRO syndrome (PMID: 31309983, 32051554). This variant is also known as p.Gly60Cys. ClinVar contains an entry for this variant (Variation ID: 436618). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RUNX1 protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on RUNX1 function (PMID: 32051554, 33692461). RNA analysis performed to evaluate the impact of this missense change on mRNA splicing indicates it does not significantly alter splicing (internal data). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The NM_001754.4:c.259G>T (p.Gly87Cys) variant is a missense variant has a REVEL score >0.75 (0.918) (PP3). AMR Subpopulation of 1000 Genomes Allele frequency 0.00144 with 1 allele out of 694 alleles. In summary, the clinical significance of this variant is uncertain (VUS). ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PP3. -
- -
Castleman-Kojima disease Pathogenic:1
- -
not specified Uncertain:1
- -
RUNX1-related disorder Uncertain:1
The RUNX1 c.259G>T variant is predicted to result in the amino acid substitution p.Gly87Cys. This variant has been reported in the literature in several individuals with iMCD-TAFRO syndrome and in a pediatric B-ALL patient (Weinberg et al. 2019, Table 4. PubMed ID: 31309983; Yoshimi et al. 2020, Table 2. PubMed ID: 32051554; Li et al. 2021, Table 1. PubMed ID: 34166225; Decker et al. 2021, Table B. PubMed ID: 33692461). Functional studies are inconclusive regarding the pathogenicity of this variant (Yoshimi et al. 2020. PubMed ID: 32051554; Decker et al. 2021. PubMed ID: 33692461; Li et al. 2021. PubMed ID: 34166225). This variant is alternatively referred to as c.178G>T p.Gly60Cys (NM_001001890) in the literature. This variant is absent in a large population database, indicating this variant is rare. This variant is interpreted as a variant of uncertain significance by multiple submitters in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/436618/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
Observed in the germline of individuals with pediatric B-ALL and iMCD-TAFRO (PMID: 31309983, 34166225); Published functional studies are conflicting regarding the effect of this variant on transcriptional activity and protein production (PMID: 32051554, 34166225, 33692461); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); Also known as p.(G60C); This variant is associated with the following publications: (PMID: 34859285, 23819521, 31978184, 33692461, 32051554, 34166225, 31309983) -
Acute myeloid leukemia Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at